To examine the relationship between RAR and ERK signaling in breast cancer cells, we first verified that expression of potential tumor-suppressive genes, HOXA5 and ELF3, was induced by RA treatment in an RAR-dependent manner in MCF7 breast cancer cells. This evidence concerns the gene ELF3 and breast carcinoma.